fda glp-1 warning november 2025 Compounded" drugs | Health Communication Research Laboratory Pharmacovigilance Assessment of Compounded GLP-1
Description
For most GLP-1 users, it is not
These medications: Improve insulin sensitivity and lower A1C
other disorders of the eye and adnexa (ICD-10: H57)
If something feels wrong, stop injecting and call your provider
Repeated injections in the same spot can cause lipodystrophy, which is essentially a breakdown or buildup of fatty tissue that creates hard lumps or indentations under the skin
